BlackRock Institutional Trust’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

BlackRock Institutional Trust’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$38.5M	Buy	767,688 +15,412	+2%	+$810K	0.01%	1510
2016 Q3	$39.5M	Buy	752,276 +31,750	+4%	+$1.52M	0.01%	1442
2016 Q2	$29.8M	Buy	720,526 +128,131	+22%	+$5.57M	﹤0.01%	1576
2016 Q1	$24.1M	Sell	592,395 -21,681	-4%	-$745K	﹤0.01%	1689
2015 Q4	$25.5M	Sell	614,076 -28,000	-4%	-$939K	﹤0.01%	1692
2015 Q3	$9.88M	Buy	642,076 +133,454	+26%	+$2.87M	﹤0.01%	2310
2015 Q2	$12.6M	Buy	508,622 +75,346	+17%	+$1.68M	﹤0.01%	2249
2015 Q1	$9.9M	Buy	433,276 +164,846	+61%	+$4.16M	﹤0.01%	2395
2014 Q4	$7.25M	Buy	268,430 +105,851	+65%	+$1.82M	﹤0.01%	2547
2014 Q3	$1.91M	Sell	162,579 -86,090	-35%	-$1.09M	﹤0.01%	3098
2014 Q2	$3.87M	Buy	248,669 +8,144	+3%	+$117K	﹤0.01%	2899
2014 Q1	$4.73M	Buy	240,525 +153,048	+175%	+$2.6M	﹤0.01%	2809
2013 Q4	$1.47M	Buy	+87,477	New	+$1.09M	﹤0.01%	3270

Other funds holding FPRX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BlackRock Institutional Trust's FPRX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Five Prime Therapeutics, Inc. (FPRX) stake by 2% in Q4 2016, buying an estimated $810K and bringing the position to 767,688 shares worth $38.5M. The position accounts for 0.01% of the portfolio, ranked #1510.

BlackRock Institutional Trust first reported a position in FPRX in Q4 2013 and has held it in 13 quarters since. The position peaked at $39.5M in Q3 2016. 172 funds tracked by Wall St. Rank hold FPRX as of Q4 2016.

BlackRock Institutional Trust held 767,688 shares of Five Prime Therapeutics, Inc. worth $38.5M as of Q4 2016.
BlackRock Institutional Trust bought 15,412 Five Prime Therapeutics, Inc. shares in Q4 2016, an estimated $810K.
Five Prime Therapeutics, Inc. made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1510 holding.
BlackRock Institutional Trust first reported a position in Five Prime Therapeutics, Inc. in Q4 2013 and has held it in 13 quarters since.
BlackRock Institutional Trust's Five Prime Therapeutics, Inc. position peaked at $39.5M in Q3 2016.
172 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.